Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00200044 · ClinicalTrials.gov registry record · NA
An Evaluation of the Medtronic Gatekeeper System in the Treatment of SUBJECTS With Gastroesophageal Reflux Disease (GERD)
A NA study, sponsored by MedtronicNeuro.
- Terminated
- Registry status
- NA
- Development phase
- 143
- Enrollment target
NCT00200044 is a NA study that was terminated before completion, run by MedtronicNeuro. The registered enrollment target is 143 participants.
The verdict
NCT00200044, a NA study, was terminated before completion, sponsored by MedtronicNeuro.
- TERMINATED
- Registry status
- NA
- Development phase
- 143 participants
- Enrollment target
Study Summary
The purpose of the study is to demonstrate the intended use of the Gatekeeper Reflux Repair System to provide symptomatic relief is subjects with gastroesophageal reflux disease.
Interventions
- DEVICE Gatekeeper Reflux Repair System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2002-12 |
| Est. Completion | 2008-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00200044
The ClinicalTrials.gov registry entry for NCT00200044 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gatekeeper Reflux Repair System is the first listed.
NCT00200044 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00200044 about?
NCT00200044 is a clinical study titled "An Evaluation of the Medtronic Gatekeeper System in the Treatment of SUBJECTS With Gastroesophageal Reflux Disease (GERD)". The purpose of the study is to demonstrate the intended use of the Gatekeeper Reflux Repair System to provide symptomatic relief is subjects with gastroesophageal reflux disease.
What is the current status of trial NCT00200044?
This trial is currently terminated. It is a NA study. The enrollment target is 143 participants. The study started on 2002-12. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00200044?
The interventions under investigation include: Gatekeeper Reflux Repair System (DEVICE).
Who is sponsoring clinical trial NCT00200044?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.